ATE180255T1 - Guanidinderivate mit therapeutischer wirkung - Google Patents
Guanidinderivate mit therapeutischer wirkungInfo
- Publication number
- ATE180255T1 ATE180255T1 AT94910453T AT94910453T ATE180255T1 AT E180255 T1 ATE180255 T1 AT E180255T1 AT 94910453 T AT94910453 T AT 94910453T AT 94910453 T AT94910453 T AT 94910453T AT E180255 T1 ATE180255 T1 AT E180255T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic action
- guanidine derivatives
- condition
- disease
- oversynthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939305997A GB9305997D0 (en) | 1993-03-23 | 1993-03-23 | Pharmaceutically active compounds |
GB939306767A GB9306767D0 (en) | 1993-03-31 | 1993-03-31 | Pharmaceutically active compounds |
GB939307741A GB9307741D0 (en) | 1993-04-15 | 1993-04-15 | Pharmaceutically active compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE180255T1 true ATE180255T1 (de) | 1999-06-15 |
Family
ID=27266630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94910453T ATE180255T1 (de) | 1993-03-23 | 1994-03-22 | Guanidinderivate mit therapeutischer wirkung |
Country Status (9)
Country | Link |
---|---|
US (2) | US5885985A (de) |
EP (1) | EP0690851B1 (de) |
AT (1) | ATE180255T1 (de) |
AU (1) | AU6286294A (de) |
DE (1) | DE69418601T2 (de) |
DK (1) | DK0690851T3 (de) |
ES (1) | ES2132393T3 (de) |
GR (1) | GR3030867T3 (de) |
WO (1) | WO1994021621A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110643A (en) * | 1993-08-12 | 1998-07-15 | Astra Ab | History of amidine, their preparation and the pharmaceutical preparations containing them |
ATE182889T1 (de) * | 1994-05-07 | 1999-08-15 | Astra Ab | Bicyclische amidinderivate als no-synthetase inhibitoren |
US5665757A (en) * | 1994-07-13 | 1997-09-09 | Robert W. Dunn | Method for treating anxiety |
GB9418912D0 (en) * | 1994-09-20 | 1994-11-09 | Fisons Corp | Pharmaceutically active compounds |
WO1996018607A1 (fr) * | 1994-12-12 | 1996-06-20 | Chugai Seiyaku Kabushiki Kaisha | Derive d'aniline inhibant la synthase du monoxyde d'azote |
WO1996021445A1 (en) * | 1995-01-13 | 1996-07-18 | The General Hospital Corporation | Methods of inhibiting neurodegenerative diseases |
SK281442B6 (sk) * | 1995-08-10 | 2001-03-12 | Astra Aktiebolag | Bicyklické amidínové deriváty, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie |
TW458978B (en) * | 1995-11-07 | 2001-10-11 | Astra Ab | Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
US6140322A (en) * | 1995-11-07 | 2000-10-31 | Astra Aktiebolag | Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
US5908842A (en) * | 1995-12-08 | 1999-06-01 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
US6756389B2 (en) * | 1996-08-09 | 2004-06-29 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
US5929085A (en) * | 1996-11-06 | 1999-07-27 | Astra Aktiebolag | Amidine and isothiourea derivatives, compositions containing them and their use as inhibitors of nitric oxide synthase |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
US6335445B1 (en) | 1997-03-24 | 2002-01-01 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
FR2761066B1 (fr) * | 1997-03-24 | 2000-11-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
FR2784678B1 (fr) * | 1998-09-23 | 2002-11-29 | Sod Conseils Rech Applic | Nouveaux derives de n-(iminomethyl)amines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
FR2783519B1 (fr) * | 1998-09-23 | 2003-01-24 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
SE9904677D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Ab | Novel compounds |
SE9904676D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Ab | Novel compounds |
EP1264820A4 (de) * | 2000-03-14 | 2004-09-15 | Fujisawa Pharmaceutical Co | Amidverbindungen |
DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
EP1767525A1 (de) * | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Guanidinoverbindungen als Melanocortin-4-Rezeptor (MC4-R) Agonisten |
AU2002356525A1 (en) * | 2001-09-24 | 2003-04-07 | Elan Pharmaceuticals, Inc. | Substituted amines for the treatment of neurological disorders |
DE10162114A1 (de) * | 2001-12-12 | 2003-06-26 | Schering Ag | Neue Amidin-Derivate und deren Verwendung in Arzneimitteln |
US20030207814A1 (en) * | 2002-02-04 | 2003-11-06 | Chiron Corporation | Novel guanidinyl derivatives |
US20030195187A1 (en) * | 2002-02-04 | 2003-10-16 | Chiron Corporation | Guanidino compounds |
US20050124652A1 (en) * | 2002-02-04 | 2005-06-09 | Rustum Boyce | Guanidino compounds |
AU2003219914A1 (en) * | 2002-02-25 | 2003-09-09 | Chiron Corporation | Intranasal administration of mc4-r agonists |
DE60333937D1 (de) * | 2002-05-23 | 2010-10-07 | Novartis Vaccines & Diagnostic | Substituierte quinazolinone verbindungen |
KR20060018217A (ko) * | 2003-05-23 | 2006-02-28 | 카이론 코포레이션 | Mc4-r 작용제로서 구아니디노-치환된 퀴나졸리논 화합물 |
AU2004293012A1 (en) | 2003-11-19 | 2005-06-09 | Rustum S. Boyce | Quinazolinone compounds with reduced bioaccumulation |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1341245A (en) * | 1971-07-08 | 1973-12-19 | Vnii Chim Sredstv Zaschity | Substituted guanidines and fungicidal compositions comprising substituted guanidines |
US3976643A (en) * | 1973-07-13 | 1976-08-24 | William H. Rorer, Inc. | Guanidines |
US4211867A (en) * | 1976-03-19 | 1980-07-08 | Mcneil Laboratories, Incorporated | Nitrogen heterocyclic carboximidamide compounds |
NZ183570A (en) * | 1976-03-19 | 1979-06-08 | Mcneilab Inc | Heterocyclic guanidine derivatives, having anti-secretory and hypogliycaemic activity |
US4414211A (en) * | 1978-09-18 | 1983-11-08 | Mcneilab, Inc. | Heterocyclic derivatives of guanidine |
US4182865A (en) * | 1978-09-18 | 1980-01-08 | Mcneil Laboratories, Inc. | Diaza-cyclic derivatives of guanidine |
CA1201119A (en) * | 1978-09-18 | 1986-02-25 | Mcneilab, Inc. | Diaza-cyclic derivatives of guanidine |
US4345083A (en) * | 1978-09-18 | 1982-08-17 | Mcneilab, Inc. | (1-Methyl-2-quinolinylidene) derivatives of guanidine |
JPS55160764A (en) * | 1979-05-29 | 1980-12-13 | Ciba Geigy Ag | Guanidine* its manufacture and pharmaceutic medicine containing same |
GR71929B (de) * | 1979-11-13 | 1983-08-19 | Ici Ltd | |
IE62023B1 (en) * | 1989-01-02 | 1994-12-14 | Boots Co Plc | Therapeutic agents |
PT96930B (pt) * | 1990-03-02 | 1998-06-30 | Univ Oregon | Metodo para a utilizacao de guanidinas tri- e tetra-substituidas como antagonistas de amino-acidos excitadores |
IN172842B (de) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
US5268373A (en) * | 1992-07-28 | 1993-12-07 | Mcneilab, Inc. | Guanidine derivatives, compositions and use |
WO1995014465A2 (en) * | 1993-11-22 | 1995-06-01 | The Johns Hopkins University | Methods for amelioration of immunodeficiency virus induced neurodegeneration by covering nitric oxide or superoxide concentration |
-
1994
- 1994-03-22 AU AU62862/94A patent/AU6286294A/en not_active Abandoned
- 1994-03-22 ES ES94910453T patent/ES2132393T3/es not_active Expired - Lifetime
- 1994-03-22 DK DK94910453T patent/DK0690851T3/da active
- 1994-03-22 EP EP94910453A patent/EP0690851B1/de not_active Expired - Lifetime
- 1994-03-22 WO PCT/GB1994/000584 patent/WO1994021621A1/en active IP Right Grant
- 1994-03-22 US US08/525,663 patent/US5885985A/en not_active Expired - Fee Related
- 1994-03-22 DE DE69418601T patent/DE69418601T2/de not_active Expired - Fee Related
- 1994-03-22 AT AT94910453T patent/ATE180255T1/de not_active IP Right Cessation
-
1998
- 1998-11-16 US US09/193,333 patent/US5998399A/en not_active Expired - Fee Related
-
1999
- 1999-07-27 GR GR990401953T patent/GR3030867T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0690851B1 (de) | 1999-05-19 |
AU6286294A (en) | 1994-10-11 |
DK0690851T3 (da) | 1999-11-08 |
EP0690851A1 (de) | 1996-01-10 |
US5885985A (en) | 1999-03-23 |
WO1994021621A1 (en) | 1994-09-29 |
ES2132393T3 (es) | 1999-08-16 |
GR3030867T3 (en) | 1999-11-30 |
US5998399A (en) | 1999-12-07 |
DE69418601T2 (de) | 1999-09-30 |
DE69418601D1 (de) | 1999-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE180255T1 (de) | Guanidinderivate mit therapeutischer wirkung | |
DK0682514T3 (da) | Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma | |
GB2284351B (en) | Terfenadine metabolites and their optically pure isomers for treating allergic disorders | |
DK1137762T3 (da) | Behandling af Pompes sygdom | |
DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
PT920865E (pt) | Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos | |
DK0673646T3 (da) | Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme | |
DE69307702T2 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
DK0571511T3 (da) | Nye urea- og thioureaforbindelser, deres fremstilling og terapeutiske anvendelse | |
RU94044455A (ru) | Средство для усиления функции макрофага и лечения человека с ослабленным иммунитетом | |
DE68926743T2 (de) | Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate | |
NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |